FdaApplication

NDA 018553

Back to search

Identifiers

Properties

PropertyValue
applicant_nameANI PHARMACEUTICALS INC
application_typeNDA
approval_date1983-04-19

Products (4)

ProductActive ingredientStrengthDosage form
INDERAL LAPROPRANOLOL HYDROCHLORIDE160MGCAPSULE, EXTENDED RELEASE;ORAL
INDERAL LAPROPRANOLOL HYDROCHLORIDE120MGCAPSULE, EXTENDED RELEASE;ORAL
INDERAL LAPROPRANOLOL HYDROCHLORIDE60MGCAPSULE, EXTENDED RELEASE;ORAL
INDERAL LAPROPRANOLOL HYDROCHLORIDE80MGCAPSULE, EXTENDED RELEASE;ORAL

4 products